CBD Global Sciences Inc. (CBDN.CN)
Stock analysis · CNQ · Healthcare · Drug Manufacturers - Specialty & Generic
CBD Global Sciences Inc. (CBDN.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About CBD Global Sciences Inc.
CBD Global Sciences Inc. operates across the entire spectrum of cannabidiol (CBD) activities, from cultivating the plant to processing it and ultimately manufacturing finished CBD products. The company provides a range of items, including raw CBD biomass, refined CBD oil, and various consumer products containing CBD oil, all distributed under its proprietary brands: Aethics, CannaOil, and Strasburg Pharms. Established in 2018, the firm maintains its primary business operations in Lakewood, Colorado.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap